This systematic review will explore the effectiveness of laparoscopic surgery (LS) in treating secondary peritonitis resulting from gastrointestinal perforation while focusing mortality, complications and recovery time. Multiple papers with different styles including retrospective analyses, randomized controlled trials, and meta-analyses are included from PubMed, Cochrane Library, Scopus, and Google Scholar Embase and CINAHL databases. Studies from2014-2025 are included. Overall laparoscopic surgery showed lower mortality rates compared to open surgery with mortality rates ranging from 1.6% to 8.82%. Reported complications were wound infections were fewer with LS, though the incidence of complications was higher. Studies show reduced recovery time associated with LS with shorter hospital stays and faster resumption of normal activities. LS also offers reduction in postoperative pain and faster return to liquid diet while demonstrating benefits in the early postoperative period. The necessity for qualified surgeons and variation in results depending on patient characteristics and surgical methods are some of issues that still exist despite these encouraging results. Higher reoperation rates and the possibility of higher healthcare expenses in specific circumstances were also noted in several research. We conclude laparoscopic surgery is a successful treatment for secondary peritonitis which is providing better results in terms of mortality, complications and recovery time; however, patient selection and surgeon skill are key factors in its effectiveness.
Background: Penetrating Crohn’s disease (CD) frequently results in fistulas, abscesses, or strictures, requiring surgery in up to 70% of cases. While laparoscopic surgery (LS) is well established in elective CD, its role in penetrating disease remains uncertain due to technical challenges and variable outcomes compared with open surgery (OS). Methods: We conducted a systematic review following PRISMA guidelines. Comparative studies (retrospective cohorts, propensity-matched analyses, randomized controlled trials, and meta-analyses) were identified through multiple databases. Primary outcomes included perioperative complications, wound infection, incisional hernia, postoperative pain, hospital stay, and disease recurrence. Results: Eight studies were included. LS was associated with reduced perioperative complications (RR 0.71, p = 0.001), lower incisional hernia risk (RR 0.24, p = 0.02), and shorter hospital stay (5 vs. 8 days, p < 0.05). Conversion to OS occurred in 10–25% of cases due to disease extent. Long-term recurrence rates were comparable between LS and OS (30% at 5 years; 60% at 10 years). Conclusion: LS provides superior short-term outcomes over OS in penetrating CD, with fewer complications and faster recovery. Long-term disease control is equivalent, and outcomes depend strongly on patient selection and surgical expertise in managing complex disease.